Pure Global AI
ANVISA registration 80020690488Valid until Aug 10, 2036

ANTI-HUMAN GLOBULIN (COOMBS)

ANVISA Registration Number: 80020690488BIO-RAD LABORATORIOS BRASIL LTDABIO-RAD LABORATORIOS BRASIL LTDA.Risk Class III
Verified
Device names
Technical name
ANTI-HUMAN GLOBULIN (COOMBS)
View exact technical-name matches →
PT: GLOBULINA ANTI-HUMANA (COOMBS)
Commercial name
Coombs-Control IgG
View exact commercial-name matches →
Risk class
Class III
Registration details
Registration Number
80020690488
Process Number
25351106435202655
CNPJ
03188198000177
Company information
Registration Holder
BIO-RAD LABORATORIOS BRASIL LTDA
Manufacturer
BIO-RAD LABORATORIOS BRASIL LTDA.
Manufacturing Country
Brazil
PT: BRASIL
Dates and status
Publication Date
Aug 10, 2026
Validity
10/08/2036
Last Updated
08/18/2026 19:00:00
About this record

Access comprehensive regulatory information for ANTI-HUMAN GLOBULIN (COOMBS) in Brazil's medical device market through Pure Global AI's free database. This Risk Class III medical device is registered under ANVISA number 80020690488 and manufactured by BIO-RAD LABORATORIOS BRASIL LTDA.. The registration is held by BIO-RAD LABORATORIOS BRASIL LTDA with validity until Aug 10, 2036.

This page shows the facts attached to this official registry row. Exact-name links return deterministic registry matches; open-ended comparison and market analysis are handed to AI Search with this record's context, without asserting that similar names represent the same entity.